Parkinson’s and the gut
Parkinson’s is often preceded by problems in the gut, and alterations in the nervous system surrounding the gut accompany the condition. In addition, the gut microbiome is emerging as an important regulator of neurodegenerative disease, and accumulating evidence has linked gut microbes to Parkinson’s symptoms and biology.
There is also emerging evidence that our immune system has significant function beyond simply fighting infection; that immune cells in the gut are programmed to relocate within the body homing in on the brain for example, to support the central nervous system (CNS). Scientists also believe that the gut microbiome might influence the brain through the neuronal circuitry that links the gut to the brain via the vagus nerve; this nerve appears to act as a physical link between our organs and the CNS.
Evidence for the vagus nerve connection stems from research of the protein alpha-synuclein in Parkinson’s; when misfolded aggregates of alpha-synuclein have been injected into the gut in laboratory models of Parkinson’s, they travel through the vagal nerve up to the brain.
This gut-brain connection could also be down to chemical messages carried via small molecules called metabolites that re made by the gut microbiome to break down food, drugs, and other natural and man-made compounds. Research has shown that some metabolites made by gut microbes, including psychoactive metabolites, can transit from the gut across the blood-brain barrier and into the brain, where they can potentially impact mood and behaviour and regulate immune cells in the brain.
Researchers have also found that this gut-brain connection isn’t only a one-way journey. Changes that happen within the CNS can also be relayed to the immune system and the gut. Studies have shown that the activation of specific neurons in the brain in response to inflammation in the gut, trigger an immune response in the gut itself; supporting the evidence of a two-way gut-brain connection.
People with Parkinson’s also exhibit differences in their microbiomes to those people without the condition, but researchers don’t yet understand why this happens. An intriguing observation about Parkinson’s is that early symptoms can include dysfunction of the gut, usually resulting in constipation, and this precedes the onset of Parkinson’s sometimes by decades.
More information about the gut
Evidence that Parkinson’s originates in the gut Clinical results from Enterin trial Gut feeling about bile acidsHow testing the gut could help in the early detection of Parkinson’s
Recent results from a Cure Parkinson’s funded study have provided more evidence for a possible role of the gut in Parkinson’s, as well as identifying new markers to aid…
A Review of Our 2023 Preclinical Projects
In 2023, Cure Parkinson’s has funded five new preclinical projects. These preclinical projects address a wide range of ‘targets’ to understand which drugs and which targets should be further…
Clinical results from Enterin trial
Biotech company Enterin has announced the results of their phase 2 clinical trial of ENT-01 indicating that it had a positive benefit on the gut symptoms associated with Parkinson’s.
Gut feeling about bile acids
Researchers have reported that the ability of gut bacteria to break down fat is disrupted in people with Parkinson’s, resulting in issues with the production of bile acid.
Parkinson’s: The absence of appendixes and tonsils
Researchers in Stockholm have recently published a report indicating that the removal of the appendix or tonsils could reduce a person’s risk of developing Parkinson’s.
Evidence that Parkinson’s originates in the gut
A new study published in the journal ‘Neuron’ has found more evidence that Parkinson’s starts in the gut
The appendix and Parkinson’s
Although its exact role isn’t yet clear because findings have been conflicting, in this easy-to-read overview the link between the appendix in the gut and risk of developing Parkinson’s…